Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Nelfinavir

  • You have access
    Nelfinavir Inhibits the Growth of Small-cell Lung Cancer Cells and Patient-derived Xenograft Tumors
    SHIGERU KAWABATA, NICK CONNIS, JOELL J. GILLS, CHRISTINE L. HANN and PHILLIP A. DENNIS
    Anticancer Research January 2021, 41 (1) 91-99; DOI: https://doi.org/10.21873/anticanres.14754
  • You have access
    Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition
    JI YEONG KIM, YOO JUNG PARK, BYUNG-MU LEE and SUNGPIL YOON
    Anticancer Research July 2019, 39 (7) 3757-3765; DOI: https://doi.org/10.21873/anticanres.13524
  • You have access
    Panobinostat and Nelfinavir Inhibit Renal Cancer Growth by Inducing Endoplasmic Reticulum Stress
    KAZUKI OKUBO, MAKOTO ISONO, TAKAKO ASANO and AKINORI SATO
    Anticancer Research October 2018, 38 (10) 5615-5626; DOI: https://doi.org/10.21873/anticanres.12896
  • You have access
    Nelfinavir Induces Endoplasmic Reticulum Stress and Sensitizes Renal Cancer Cells to TRAIL
    KAZUKI OKUBO, AKINORI SATO, MAKOTO ISONO, TAKAKO ASANO and TOMOHIKO ASANO
    Anticancer Research August 2018, 38 (8) 4505-4514; DOI: https://doi.org/10.21873/anticanres.12754
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire